ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Executive Director, US Portfolio Analytics at Revolution Medicines - ApplyBlast

Executive Director, US Portfolio Analytics

Revolution Medicines

29 days ago

3.5 on Glassdoor

Redwood City, California, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Executive Director, US Portfolio Analytics leads portfolio-wide analytics capabilities to enable data-driven commercial decision-making across the US business. This strategic role serves as a thought partner to commercial leadership, translating business priorities into an integrated analytics roadmap while building and developing a high-performing team. The position oversees field analytics, market access analytics, data strategy, omnichannel analytics, and reporting to support launch readiness and performance management.

Responsibilities

Lead portfolio-wide analytics capabilities and define the vision for US commercial decision-making
Oversee field analytics, market access analytics, and omnichannel analytics teams and strategies
Own commercial analytics data strategy, governance, and cross-functional data architecture partnerships

Skills

Qualifications

Bachelor's degree in quantitative, scientific, engineering, or business discipline(s)

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.